Viking Holdings (VIK) shares set another all-time high on Tuesday with a gain of 1.6%, while shares of Carnival (CCL), ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

When it comes to pre-revenue biotechs, it's often a struggle to build an investment thesis beyond "if the medicine works, the ...

Diverse Markets Management’s holiday market has a new name and location this year. At DC Holiday Market—formerly Downtown ...

The earnings results for Hyatt Hotels H for Q3 were made public on Thursday, October 31, 2024 at 06:55 AM. Here's a ...

The latest earnings report from Viking Holdings on August 22, 2024 showed a downturn in performance, with results falling ...

Obesity pill data released by Viking Therapeutics Inc and AstraZeneca Plc at a big conference foreshadowed an increasingly ...

AstraZeneca PLC shed GBP15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company (UK:AZN) said its lead product ...

Promising data don’t always equal a stock pop. Viking Therapeutics presented what analysts thought were compelling data on an oral GLP-1/GIP dual agonist on Sunday ...

Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of ...